Skip to main content
Caplight Logo









Until Labs

Until Labs

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.untillabs.com/

Last Round

Series A

Sep 22, 2025

Total Funding Raised

$48M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Until Labs is a biotechnology company that develops perfusion hardware, cryoprotective agents, and rewarming infrastructure for organ-scale reversible cryopreservation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

cryopreservationorgan preservationvitrificationbiotechnologyorgan transplantcryobiologymedical hardwareperfusion systemscryoprotectantrewarming technologybiopreservationorgan logisticstransplant technologycryonicsdeep freeze

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Until Labs Comparables

Compare Until Labs with similar companies based on industry and business-model similarity.

Until Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
X-Therma
84%
Bridge to Life
75%
21st Century Medicine, Inc.
74%

Until Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 22, 2025
SeedJun 6, 2024

Key People

Founding team and executive leadership

Laura Deming

CEO, Co-founder

Founding Team

Until Labs Investors

Notable investors and investment history

Until Labs investors
InvestorRounds
Field VenturesSeries A
Field VenturesSeries A
Founders FundSeries A
Lux CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 22, 2025

    $58M round led by Founders Fund.

  • Jun 6, 2024

    $48M raised in Seed round.

Until Labs Filings

Explore SEC and related filing metadata, where available.

Until Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Until Labs's valuation, stock price, and market status.

Is Until Labs a public or private company?

Until Labs is a private company.

What is the current stock price of Until Labs?

Until Labs is a private company with no public stock price. No recent secondary market data is available.

How much is Until Labs worth (valuation)?

Valuation information for Until Labs is not publicly available.

Can I buy Until Labs stock?

Until Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Until Labs's last funding round?

Until Labs's most recent funding round was Series A on September 22, 2025.

Who are the main investors in Until Labs?

Key investors in Until Labs include Founders Fund.

Will Until Labs IPO soon?

No public IPO plans have been announced for Until Labs.

How can I track Until Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Until Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range40
Year Founded2024
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?